Inspira Technologies to Unveil HYLA Blood Sensor
Ticker: IINNW · Form: 6-K · Filed: Sep 18, 2025 · CIK: 1837493
Sentiment: bullish
Topics: product-launch, medical-technology, accuracy-data
TL;DR
Inspira's HYLA blood sensor hits 97.35% accuracy, launching at U.S. ELSO.
AI Summary
On September 18, 2025, Inspira Technologies Oxy B.H.N. Ltd. announced it will unveil its HYLA™ Real-Time Blood Sensor at the U.S. ELSO conference. The company confirmed the sensor achieved 97.35% accuracy, a significant development in blood monitoring technology.
Why It Matters
The HYLA sensor's high accuracy could revolutionize blood monitoring, potentially leading to faster diagnoses and improved patient care in critical settings.
Risk Assessment
Risk Level: medium — The filing is a routine update and does not contain significant financial or operational news, but the technology's success is still unproven in widespread commercial application.
Key Numbers
- 97.35% — Sensor Accuracy (Confirmed accuracy of the HYLA™ Real-Time Blood Sensor)
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- HYLA™ Real-Time Blood Sensor (product) — New technology to be unveiled
- U.S. ELSO (event) — Conference where sensor will be unveiled
- September 18, 2025 (date) — Date of press release
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K filing is to report a press release issued by Inspira Technologies Oxy B.H.N. Ltd. on September 18, 2025, announcing the upcoming unveiling of their HYLA™ Real-Time Blood Sensor at the U.S. ELSO conference.
What is the confirmed accuracy of the HYLA™ Real-Time Blood Sensor?
The press release states that the HYLA™ Real-Time Blood Sensor has achieved 97.35% accuracy.
Where will the HYLA™ Real-Time Blood Sensor be unveiled?
The HYLA™ Real-Time Blood Sensor will be unveiled at the U.S. ELSO conference.
What is the company's full name as listed in the filing?
The company's full name is Inspira Technologies Oxy B.H.N. Ltd.
What is the significance of the 'Report No. 4' in the filing title?
The 'Report No. 4' indicates this is the fourth report filed by the company for the month of September 2025, as per the requirements for foreign private issuers.
Filing Stats: 318 words · 1 min read · ~1 pages · Grade level 8 · Accepted 2025-09-18 08:00:09
Filing Documents
- ea0257867-6k_inspira.htm (6-K) — 12KB
- ea025786701ex99-1_inspira.htm (EX-99.1) — 9KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001213900-25-088772.txt ( ) — 25KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: September 18, 2025 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2